Glycolysis and Oxidative Phosphorylation Play Critical Roles in Natural Killer Cell Receptor-Mediated Natural Killer Cell Functions

Natural killer (NK) cells are innate lymphocytes that directly kill tumor and pathogen-infected cells upon activation by cytokines and NK cell receptors (NKRs) without previous sensitization. It is known that cell metabolism affects the differentiation and effector functions of immune cells. For ins...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 11; p. 202
Main Authors Wang, Zixi, Guan, Di, Wang, Shu, Chai, Louis Yi Ann, Xu, Shengli, Lam, Kong-Peng
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 20.02.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Natural killer (NK) cells are innate lymphocytes that directly kill tumor and pathogen-infected cells upon activation by cytokines and NK cell receptors (NKRs) without previous sensitization. It is known that cell metabolism affects the differentiation and effector functions of immune cells. For instance, interleukin-2 and interleukin-15 treatment increases glycolysis and oxidative phosphorylation (OXPHOS) in NK cells to support their effector functions. However, little is known about the metabolic reprogramming of human NK cells upon their activation by NKRs. In this study, we investigated the metabolism of NK cells stimulated via NKRs. We found that NK cells upregulated glycolysis and OXPHOS in response to anti-CD16 antibody or NKG2D ligand engagement. Inhibition of either glycolysis or OXPHOS impaired NK cell production of interferon-γ. Interestingly, inhibition of glycolysis but not OXPHOS decreased NK cell killing and dampened NK cell degranulation and Fas ligand expression, suggesting that glycolysis is more critical for NKR-activated cell cytotoxicity. Thus, our study provides insight into understanding the metabolic requirements underlying different effector functions of human NK cells.
AbstractList Natural killer (NK) cells are innate lymphocytes that directly kill tumor and pathogen-infected cells upon activation by cytokines and NK cell receptors (NKRs) without previous sensitization. It is known that cell metabolism affects the differentiation and effector functions of immune cells. For instance, interleukin-2 and interleukin-15 treatment increases glycolysis and oxidative phosphorylation (OXPHOS) in NK cells to support their effector functions. However, little is known about the metabolic reprogramming of human NK cells upon their activation by NKRs. In this study, we investigated the metabolism of NK cells stimulated via NKRs. We found that NK cells upregulated glycolysis and OXPHOS in response to anti-CD16 antibody or NKG2D ligand engagement. Inhibition of either glycolysis or OXPHOS impaired NK cell production of interferon-γ. Interestingly, inhibition of glycolysis but not OXPHOS decreased NK cell killing and dampened NK cell degranulation and Fas ligand expression, suggesting that glycolysis is more critical for NKR-activated cell cytotoxicity. Thus, our study provides insight into understanding the metabolic requirements underlying different effector functions of human NK cells.
Natural killer (NK) cells are innate lymphocytes that directly kill tumor and pathogen-infected cells upon activation by cytokines and NK cell receptors (NKRs) without previous sensitization. It is known that cell metabolism affects the differentiation and effector functions of immune cells. For instance, interleukin−2 and interleukin−15 treatment increases glycolysis and oxidative phosphorylation (OXPHOS) in NK cells to support their effector functions. However, little is known about the metabolic reprogramming of human NK cells upon their activation by NKRs. In this study, we investigated the metabolism of NK cells stimulated via NKRs. We found that NK cells upregulated glycolysis and OXPHOS in response to anti-CD16 antibody or NKG2D ligand engagement. Inhibition of either glycolysis or OXPHOS impaired NK cell production of interferon-γ. Interestingly, inhibition of glycolysis but not OXPHOS decreased NK cell killing and dampened NK cell degranulation and Fas ligand expression, suggesting that glycolysis is more critical for NKR-activated cell cytotoxicity. Thus, our study provides insight into understanding the metabolic requirements underlying different effector functions of human NK cells.
Author Guan, Di
Wang, Shu
Xu, Shengli
Wang, Zixi
Chai, Louis Yi Ann
Lam, Kong-Peng
AuthorAffiliation 5 Division of Infectious Diseases, University Medicine Cluster, National University Health System , Singapore , Singapore
7 Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore , Singapore , Singapore
4 Department of Biological Sciences, National University of Singapore , Singapore , Singapore
1 Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore , Singapore , Singapore
3 NUS Graduate School for Integrative Sciences & Engineering (NGS), National University of Singapore , Singapore , Singapore
6 Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore , Singapore , Singapore
2 Bioprocessing Technology Institute, Agency for Science, Technology and Research , Singapore , Singapore
AuthorAffiliation_xml – name: 4 Department of Biological Sciences, National University of Singapore , Singapore , Singapore
– name: 1 Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore , Singapore , Singapore
– name: 2 Bioprocessing Technology Institute, Agency for Science, Technology and Research , Singapore , Singapore
– name: 7 Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore , Singapore , Singapore
– name: 5 Division of Infectious Diseases, University Medicine Cluster, National University Health System , Singapore , Singapore
– name: 6 Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore , Singapore , Singapore
– name: 3 NUS Graduate School for Integrative Sciences & Engineering (NGS), National University of Singapore , Singapore , Singapore
Author_xml – sequence: 1
  givenname: Zixi
  surname: Wang
  fullname: Wang, Zixi
  organization: Bioprocessing Technology Institute, Agency for Science, Technology and Research, Singapore, Singapore
– sequence: 2
  givenname: Di
  surname: Guan
  fullname: Guan, Di
  organization: NUS Graduate School for Integrative Sciences & Engineering (NGS), National University of Singapore, Singapore, Singapore
– sequence: 3
  givenname: Shu
  surname: Wang
  fullname: Wang, Shu
  organization: Department of Biological Sciences, National University of Singapore, Singapore, Singapore
– sequence: 4
  givenname: Louis Yi Ann
  surname: Chai
  fullname: Chai, Louis Yi Ann
  organization: Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
– sequence: 5
  givenname: Shengli
  surname: Xu
  fullname: Xu, Shengli
  organization: Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
– sequence: 6
  givenname: Kong-Peng
  surname: Lam
  fullname: Lam, Kong-Peng
  organization: Bioprocessing Technology Institute, Agency for Science, Technology and Research, Singapore, Singapore
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32153568$$D View this record in MEDLINE/PubMed
BookMark eNptUk1v1DAQtVARLUvvnJCPXLL4K97kgoRWbakotEJwthx70nXl2IudVOTMH8e7W6pWwgePPR9v_DzvNToKMQBCbylZct60H3o3DNOSEUaWpGzsBTqhUoqKMyaOnpyP0WnOd6Qs0XLO61fomDNa81o2J-jPhZ9N9HN2Getg8fVvZ_Xo7gHfbGLebmKafbnHgG-8nvE6udEZ7fH36CFjF_A3PU6pOL447yHhNfgSBAPbMabqK1inR7D_zTqfgtkh5zfoZa99htMHu0A_z89-rD9XV9cXl-tPV5WpWTNWLXAm20KCNX0xnQXZNbajbSs0qQUzbU9FS4ABWelGWlPYUsOstNII2a74Al0ecG3Ud2qb3KDTrKJ2au-I6VbpVOh5UEZ3fW9FIw3tBZi6E4RKKG0stbUBW7A-HrC2UzeANRDGwu8Z6PNIcBt1G-_Vioh6N4gFev8AkOKvCfKoBpdN-RcdIE5ZMb6qGykpFSWVHFJNijkn6B_bUKJ2UlB7KaidFNReCqXk3dPnPRb8Gzz_Cz3itPY
CitedBy_id crossref_primary_10_1038_s41385_021_00404_8
crossref_primary_10_1016_j_intimp_2022_109193
crossref_primary_10_3390_cells10071715
crossref_primary_10_3390_cancers14092339
crossref_primary_10_1016_j_intimp_2024_111791
crossref_primary_10_3390_ijms24087267
crossref_primary_10_1111_imr_13316
crossref_primary_10_3390_cells11101663
crossref_primary_10_1016_j_mbs_2023_109044
crossref_primary_10_1016_j_tips_2023_08_009
crossref_primary_10_2217_epi_2022_0454
crossref_primary_10_1038_s41586_022_05254_3
crossref_primary_10_1111_imr_13314
crossref_primary_10_1016_j_celrep_2023_112661
crossref_primary_10_3389_fimmu_2022_1038650
crossref_primary_10_3390_cells12121604
crossref_primary_10_1186_s12943_020_01238_x
crossref_primary_10_2116_analsci_21P117
crossref_primary_10_3389_fimmu_2023_1064101
crossref_primary_10_1136_jitc_2022_006533
crossref_primary_10_1016_j_xcrm_2023_101150
crossref_primary_10_3389_fimmu_2024_1384039
crossref_primary_10_1128_spectrum_04520_22
crossref_primary_10_3390_cells11050768
crossref_primary_10_1186_s12943_021_01316_8
crossref_primary_10_3389_fimmu_2022_861290
crossref_primary_10_15252_embj_2021107739
crossref_primary_10_1097_IN9_0000000000000020
crossref_primary_10_55230_mabjournal_v52i6_2413
crossref_primary_10_3389_fimmu_2023_1303605
crossref_primary_10_1111_pai_13583
crossref_primary_10_1186_s12964_024_01718_3
crossref_primary_10_1038_s41401_024_01304_w
crossref_primary_10_3390_neurosci5020016
crossref_primary_10_1007_s10528_023_10345_5
crossref_primary_10_1038_s41598_022_15743_0
crossref_primary_10_3389_fimmu_2021_619195
crossref_primary_10_1172_jci_insight_173099
crossref_primary_10_3389_fimmu_2022_893137
crossref_primary_10_1186_s13287_022_02769_4
crossref_primary_10_3390_ijms24065498
crossref_primary_10_1158_2326_6066_CIR_21_0813
crossref_primary_10_1172_jci_insight_151420
crossref_primary_10_3390_cancers14071698
crossref_primary_10_3389_fimmu_2023_1107298
crossref_primary_10_1016_j_clim_2023_109322
crossref_primary_10_1016_j_jare_2024_04_014
crossref_primary_10_1186_s13046_023_02724_y
crossref_primary_10_1186_s12865_020_00382_9
crossref_primary_10_1186_s13046_023_02917_5
crossref_primary_10_1038_s41590_020_00848_3
crossref_primary_10_4049_jimmunol_2300406
crossref_primary_10_1016_j_genrep_2022_101514
crossref_primary_10_1111_imm_13461
crossref_primary_10_1186_s12967_024_05033_w
crossref_primary_10_1096_fj_202301230R
crossref_primary_10_1002_JLB_5MR0920_198RR
crossref_primary_10_1002_mco2_16
crossref_primary_10_1007_s00253_021_11313_y
crossref_primary_10_1016_j_phrs_2023_106929
crossref_primary_10_1038_s41598_023_48018_3
crossref_primary_10_1177_15347354221150787
crossref_primary_10_1242_jcs_261655
crossref_primary_10_3389_fimmu_2022_771732
crossref_primary_10_1186_s12943_023_01893_w
crossref_primary_10_3390_cancers15123225
crossref_primary_10_3389_fimmu_2022_875072
crossref_primary_10_3390_cancers13081904
Cites_doi 10.1158/1078-0432.CCR-14-2146
10.1016/j.jaci.2018.06.047
10.4049/jimmunol.156.12.4707
10.1016/j.molimm.2004.07.034
10.1016/j.immuni.2013.04.005
10.4049/jimmunol.1402099
10.4049/jimmunol.1401558
10.1038/nm.4399
10.1038/nri3174
10.4049/jimmunol.1501783
10.1016/j.omto.2019.12.006
10.1038/nrc928
10.1073/pnas.1112520108
10.1126/scisignal.aad1884
10.1084/jem.188.12.2375
10.1146/annurev.iy.03.040185.000335
10.3389/fimmu.2018.03020
10.1158/0008-5472.CAN-08-3712
10.1016/j.cell.2013.05.016
10.1038/nri1863
10.1186/s12865-018-0272-x
10.4049/jimmunol.1400271
10.1126/science.1198687
10.1016/S1074-7613(02)00333-3
10.1182/blood-2005-04-1351
10.1016/S0065-2776(08)60664-1
ContentType Journal Article
Copyright Copyright © 2020 Wang, Guan, Wang, Chai, Xu and Lam.
Copyright © 2020 Wang, Guan, Wang, Chai, Xu and Lam. 2020 Wang, Guan, Wang, Chai, Xu and Lam
Copyright_xml – notice: Copyright © 2020 Wang, Guan, Wang, Chai, Xu and Lam.
– notice: Copyright © 2020 Wang, Guan, Wang, Chai, Xu and Lam. 2020 Wang, Guan, Wang, Chai, Xu and Lam
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.3389/fimmu.2020.00202
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1664-3224
EndPage 202
ExternalDocumentID oai_doaj_org_article_cabffd486c1f4ec5b4016ea05d1d5ced
10_3389_fimmu_2020_00202
32153568
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CGR
CUY
CVF
DIK
EBS
ECM
EIF
EMOBN
GROUPED_DOAJ
GX1
HYE
IAO
IEA
IHR
IHW
IPNFZ
KQ8
M48
M~E
NPM
OK1
PGMZT
RIG
RNS
RPM
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c528t-9e326904928f904bde6b8db1994a0542c9f1490e2e07a86dc9331c2d6d6c46973
IEDL.DBID RPM
ISSN 1664-3224
IngestDate Tue Oct 22 15:11:14 EDT 2024
Tue Sep 17 21:15:46 EDT 2024
Sat Oct 05 06:14:18 EDT 2024
Thu Sep 26 15:47:01 EDT 2024
Sat Sep 28 08:28:40 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords anti-tumor
natural killer cells
CD16
NKG2D
cell metabolism
glycolysis
Language English
License Copyright © 2020 Wang, Guan, Wang, Chai, Xu and Lam.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c528t-9e326904928f904bde6b8db1994a0542c9f1490e2e07a86dc9331c2d6d6c46973
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Eleanor Riley, University of Edinburgh, United Kingdom
Reviewed by: Alexander Steinle, Goethe University Frankfurt, Germany; Subramaniam Malarkannan, Medical College of Wisconsin, United States
This article was submitted to NK and Innate Lymphoid Cell Biology, a section of the journal Frontiers in Immunology
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045049/
PMID 32153568
PQID 2375866114
PQPubID 23479
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_cabffd486c1f4ec5b4016ea05d1d5ced
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7045049
proquest_miscellaneous_2375866114
crossref_primary_10_3389_fimmu_2020_00202
pubmed_primary_32153568
PublicationCentury 2000
PublicationDate 2020-02-20
PublicationDateYYYYMMDD 2020-02-20
PublicationDate_xml – month: 02
  year: 2020
  text: 2020-02-20
  day: 20
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in immunology
PublicationTitleAlternate Front Immunol
PublicationYear 2020
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Soriani (B26) 2014; 193
Keppel (B11) 2015; 194
Fogler (B3) 1996; 156
Pfeifer (B23) 2018; 9
Smyth (B19) 2005; 42
Bryceson (B17) 2006; 107
Ng (B15) 2020; 16
Chang (B20) 2013; 153
Alvarez-Calderon (B25) 2015; 21
Viel (B14) 2016; 9
Trinchieri (B2) 1989; 47
Smyth (B1) 2002; 2
Vivier (B6) 2011; 331
Schafer (B22) 2019; 143
Henkart (B4) 1985; 3
Fujisaki (B16) 2009; 69
Raulet (B7) 2006; 6
Denton (B21) 2011; 108
Vivier (B8) 2012; 12
Jamieson (B9) 2002; 17
Tremblay-McLean (B18) 2019; 20
Pearce (B10) 2013; 38
Donnelly (B12) 2014; 193
Zamai (B5) 1998; 188
Keating (B13) 2016; 196
Kuntz (B24) 2017; 23
References_xml – volume: 21
  start-page: 1360
  year: 2015
  ident: B25
  article-title: Tyrosine kinase inhibition in leukemia induces an altered metabolic state sensitive to mitochondrial perturbations
  publication-title: Clin Cancer Res.
  doi: 10.1158/1078-0432.CCR-14-2146
  contributor:
    fullname: Alvarez-Calderon
– volume: 143
  start-page: 346
  year: 2019
  ident: B22
  article-title: Education-dependent activation of glycolysis promotes the cytolytic potency of licensed human natural killer cells
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2018.06.047
  contributor:
    fullname: Schafer
– volume: 156
  start-page: 4707
  year: 1996
  ident: B3
  article-title: NK cell infiltration into lung, liver, and subcutaneous B16 melanoma is mediated by VCAM-1/VLA-4 interaction
  publication-title: J Immunol
  doi: 10.4049/jimmunol.156.12.4707
  contributor:
    fullname: Fogler
– volume: 42
  start-page: 501
  year: 2005
  ident: B19
  article-title: Activation of NK cell cytotoxicity
  publication-title: Mol Immunol
  doi: 10.1016/j.molimm.2004.07.034
  contributor:
    fullname: Smyth
– volume: 38
  start-page: 633
  year: 2013
  ident: B10
  article-title: Metabolic pathways in immune cell activation and quiescence
  publication-title: Immunity
  doi: 10.1016/j.immuni.2013.04.005
  contributor:
    fullname: Pearce
– volume: 194
  start-page: 1954
  year: 2015
  ident: B11
  article-title: Activation-specific metabolic requirements for NK Cell IFN-gamma production
  publication-title: J Immunol.
  doi: 10.4049/jimmunol.1402099
  contributor:
    fullname: Keppel
– volume: 193
  start-page: 4477
  year: 2014
  ident: B12
  article-title: mTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1401558
  contributor:
    fullname: Donnelly
– volume: 23
  start-page: 1234
  year: 2017
  ident: B24
  article-title: Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells
  publication-title: Nat Med
  doi: 10.1038/nm.4399
  contributor:
    fullname: Kuntz
– volume: 12
  start-page: 239
  year: 2012
  ident: B8
  article-title: Targeting natural killer cells and natural killer T cells in cancer
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri3174
  contributor:
    fullname: Vivier
– volume: 196
  start-page: 2552
  year: 2016
  ident: B13
  article-title: Metabolic reprogramming supports IFN-gamma production by CD56bright NK cells
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1501783
  contributor:
    fullname: Keating
– volume: 16
  start-page: 75
  year: 2020
  ident: B15
  article-title: CXCR1 expression to improve anti-cancer efficacy of intravenously injected CAR-NK cells in mice with peritoneal xenografts
  publication-title: Mol Ther Oncol
  doi: 10.1016/j.omto.2019.12.006
  contributor:
    fullname: Ng
– volume: 2
  start-page: 850
  year: 2002
  ident: B1
  article-title: New aspects of natural-killer-cell surveillance and therapy of cancer
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc928
  contributor:
    fullname: Smyth
– volume: 108
  start-page: 15306
  year: 2011
  ident: B21
  article-title: Differentiation-dependent functional and epigenetic landscapes for cytokine genes in virus-specific CD8+ T cells
  publication-title: Proc Natl. Acad Sci USA
  doi: 10.1073/pnas.1112520108
  contributor:
    fullname: Denton
– volume: 9
  start-page: ra19
  year: 2016
  ident: B14
  article-title: TGF-beta inhibits the activation and functions of NK cells by repressing the mTOR pathway
  publication-title: Science Signal
  doi: 10.1126/scisignal.aad1884
  contributor:
    fullname: Viel
– volume: 188
  start-page: 2375
  year: 1998
  ident: B5
  article-title: Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells
  publication-title: J Exp Med.
  doi: 10.1084/jem.188.12.2375
  contributor:
    fullname: Zamai
– volume: 3
  start-page: 31
  year: 1985
  ident: B4
  article-title: Mechanism of lymphocyte-mediated cytotoxicity
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.iy.03.040185.000335
  contributor:
    fullname: Henkart
– volume: 9
  start-page: 3020
  year: 2018
  ident: B23
  article-title: Natural killer cell education is associated with a distinct glycolytic profile
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2018.03020
  contributor:
    fullname: Pfeifer
– volume: 69
  start-page: 4010
  year: 2009
  ident: B16
  article-title: Expansion of highly cytotoxic human natural killer cells for cancer cell therapy
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-08-3712
  contributor:
    fullname: Fujisaki
– volume: 153
  start-page: 1239
  year: 2013
  ident: B20
  article-title: Posttranscriptional control of T cell effector function by aerobic glycolysis
  publication-title: Cell
  doi: 10.1016/j.cell.2013.05.016
  contributor:
    fullname: Chang
– volume: 6
  start-page: 520
  year: 2006
  ident: B7
  article-title: Self-tolerance of natural killer cells
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri1863
  contributor:
    fullname: Raulet
– volume: 20
  start-page: 8
  year: 2019
  ident: B18
  article-title: Expression of ligands for activating natural killer cell receptors on cell lines commonly used to assess natural killer cell function
  publication-title: BMC Immunol.
  doi: 10.1186/s12865-018-0272-x
  contributor:
    fullname: Tremblay-McLean
– volume: 193
  start-page: 950
  year: 2014
  ident: B26
  article-title: Reactive oxygen species- and DNA damage response-dependent NK cell activating ligand upregulation occurs at transcriptional levels and requires the transcriptional factor E2F1
  publication-title: J Immunol.
  doi: 10.4049/jimmunol.1400271
  contributor:
    fullname: Soriani
– volume: 331
  start-page: 44
  year: 2011
  ident: B6
  article-title: Innate or adaptive immunity? The example of natural killer cells
  publication-title: Science.
  doi: 10.1126/science.1198687
  contributor:
    fullname: Vivier
– volume: 17
  start-page: 19
  year: 2002
  ident: B9
  article-title: The role of the NKG2D immunoreceptor in immune cell activation and natural killing
  publication-title: Immunity
  doi: 10.1016/S1074-7613(02)00333-3
  contributor:
    fullname: Jamieson
– volume: 107
  start-page: 159
  year: 2006
  ident: B17
  article-title: Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion
  publication-title: Blood
  doi: 10.1182/blood-2005-04-1351
  contributor:
    fullname: Bryceson
– volume: 47
  start-page: 187
  year: 1989
  ident: B2
  article-title: Biology of natural killer cells
  publication-title: Adv Immunol
  doi: 10.1016/S0065-2776(08)60664-1
  contributor:
    fullname: Trinchieri
SSID ssj0000493335
Score 2.5584347
Snippet Natural killer (NK) cells are innate lymphocytes that directly kill tumor and pathogen-infected cells upon activation by cytokines and NK cell receptors (NKRs)...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 202
SubjectTerms anti-tumor
Antibodies - immunology
Antibodies - pharmacology
Blood Donors
CD16
Cell Degranulation
cell metabolism
Cells, Cultured
Cytotoxicity, Immunologic - drug effects
Fas Ligand Protein - metabolism
glycolysis
Glycolysis - drug effects
GPI-Linked Proteins - immunology
Humans
Immunology
Interferon-gamma - biosynthesis
Killer Cells, Natural - immunology
Killer Cells, Natural - metabolism
Ligands
Lymphocyte Activation - drug effects
natural killer cells
NK Cell Lectin-Like Receptor Subfamily K - metabolism
NKG2D
Oxidative Phosphorylation - drug effects
Receptors, IgG - immunology
Receptors, Natural Killer Cell - metabolism
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3PSyMxFA4iCF6WXdfdnd1VsuDFw-A0mWQyRxVr2aW1iIK3kJ-0UmektrA9-4_vS9JKK4KXPQ10Uia877X5vsnL9xA6ApKhPC117m3YZqTM5zW3Rc64oqUzuvQu7Oj2B7x3W_6-Y3drrb5CTViyB06BOzFKe29LwU3Hw5eZBkHAnSqY7VhmnI3_vgVZE1P3ifdSSlnalwQVVp_48cPDHPQgCaVcZPkWZbUORbv-tzjm61LJtbWn-xF9WJJGfJom-wltuWYP7aQ2kovP6PlysgA8g7cIVo3FV3_HNvp54-GofXoctdNFqnjDw4la4FV3A3wdzJzwuMEDFd038J94MBCfuwncdKHgpZ3m_djMw9k3R3VhWYyZu49uuxc357182VwhN4yIWV47IG41xIkIDxdtHdfC6mAVDMEtiak9iKfCEVdUSnBrIKAdQyy33ICkrugXtN20jfuGsIahxgB50gbkYmm1qHQhjKbCArsyLEPHq1DLx-ShIUF7BFhkhEUGWGSEJUNnAYuXccH9On4AOSGXOSHfy4kM_VohKeHXErZAVOPa-ZMkFPQRUJJOmaGvCdmXR1FgP5RxkaFqA_ONuWzeacaj6MhdATGGUH7_H5P_gXZDOOKx-eIn2p5N5-4AiM9MH8Yc_wc8jAcX
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1dixMxFA2yIvgifjt-EcEXH0anySSTPojoYl2UrotY2LeQz22lO7NOW9h59o97b2a6WumjTwOdlAn3JNxzyM25hLwEkmEiL20ePR4zchHzsfRFLqThZXC2jAFPdKfH8mhWfj4Vp3-uRw8BXO2VdthPatYuX1_-7N7Bhn-LihPy7Zu4OD_fgNRjWKXF0FnyOoO8iAVe04Hs_-i5MOdc9GeVe_-4k5uShf8-3vlv-eRf-Whym9waiCR93yN_h1wL9V1yo28t2d0jvz4tO8AY_UaoqT39ernwyeObnsyb1cW8abu-Co6eLE1Htx0P6Dc0eKKLmh6b5MhBv6TLgvQwLOFlwCKYps2nqcFH8HtHTSBVptV8n8wmH78fHuVDw4XcCabW-TgAmRtDnJiK8LA-SKu8RftgA9SOuXEEQVUEForKKOkdBHTkmJdeOpDZFX9ADuqmDo8ItTDUOSBU1oGELL1VlS2Us1x5YFxOZOTVNtT6ovfV0KBHEBadYNEIi06wZOQDYnE1Dh2x0w9Ne6aHDaadsTH6Ukk3irDIhAXhKANM24-8cMFn5MUWSQ07CI9FTB2azUozDpoJaMqozMjDHtmrT3FgRFxIlZFqB_Oduey-qRfz5NJdAVmGUD7-H5N_Qm5iONJV-uIpOVi3m_AMyNDaPk9r_DdcyA4e
  priority: 102
  providerName: Scholars Portal
Title Glycolysis and Oxidative Phosphorylation Play Critical Roles in Natural Killer Cell Receptor-Mediated Natural Killer Cell Functions
URI https://www.ncbi.nlm.nih.gov/pubmed/32153568
https://search.proquest.com/docview/2375866114
https://pubmed.ncbi.nlm.nih.gov/PMC7045049
https://doaj.org/article/cabffd486c1f4ec5b4016ea05d1d5ced
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1da9swFL20hY2-jH3P-yga7GUPbmzLkuXHLSwtG-nCWCFvwvpqPBI7pAksz_vju5Ljkow-7cUGW8ZC55p7jnV1BPABSUblaK5iZ_w0I2UuLrlJYsYrmlutcmf9jO74il9e51-nbHoErF8LE4r2tarPm_nivKlnobZyudCDvk5sMBkPC-QhyGwHx3CM6XdPov_qKC-llHVTkijAyoGrF4sNSsHMV3Hh6RQeUsx0lHl_1b1sFEz772Oa_xZM7mWg0WN4tKOO5FPXxSdwZJun8KDbTHL7DP5czLeIqncYIVVjyPfftQmu3mQya2-Xs3a17ereyGRebUm_xwH54S2dSN2Qqyp4cJBvYXkgGdo53rS-7KVdxeOwpYc197YaYXIM8fscrkdffg4v490WC7FmmVjHpUX6VuKQZcLhSRnLlTDKGwZXSOYyXTqUUInNbFJUghuNY5vqzHDDNQrrgr6Ak6Zt7CsgCptqjRRKaRSNuVGiUInQigqDHEuzCD72Qy2XnZOGRAXiEZIBIekRkgGhCD57LO7aeQ_scKFd3chdJEhdKedMLrhOHYYVUygVucVum9QwbU0E73skJX4zfiKkamy7uZUZRZWExCTNI3jZIXv3qj4yIigOMD_oy-EdDNPgy70Ly9f__eQbOPVjEFbMJ2_hZL3a2HfIedbqLPwrwOPFNMXjOBdnIer_Aj5jCBI
link.rule.ids 230,314,727,780,784,864,885,2102,24318,27924,27925,53791,53793
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFL0aQ8BeEN8Ln0bihYesSRw7ySNUlMLWUqFN2psVf9FMbVJ1rUSf-eNcO83Uoj3xZCl2FMvnRj5Hvj4X4AOSjNLSVIZWu2NGymxYcB2FjJc0NUqm1rgT3dGYDy_S75fs8gBYdxfGJ-0rWZ3Us_lJXU19buVirnpdnlhvMupnyEOQ2fbuwF1GsyLeEelXLemllLL2UBIlWNGz1Xy-RjGYuDwubI7gPsW9jjLnsLqzH3nb_tu45r8pkzt70OARPNySR_KpneRjODD1E7jXlpPcPIU_X2cbxNV5jJCy1uTH70p7X28ymTbXi2mz3LSZb2QyKzekq3JAfjpTJ1LVZFx6Fw5y6i8Ikr6ZYadxiS_NMhz5oh5G3zpqgNujj-BncDH4ct4fhtsiC6FiSb4KC4MErsAlS3KLjdSGy1xLZxlcIp1LVGFRREUmMVFW5lwrXNtYJZprrlBaZ_Q5HNZNbY6BSByqFJIoqVA2plrmmYxyJWmukWUpFsDHbqnFovXSEKhBHELCIyQcQsIjFMBnh8XNOOeC7R80y19iGwtCldJaneZcxRYDi0kUi9zgtHWsmTI6gPcdkgL_GncUUtamWV-LhKJOQmoSpwG8aJG9-VQXGQFke5jvzWW_BwPVO3NvA_Plf7_5Dh4Mz0dn4uzb-PQVHLn18Pfno9dwuFquzRtkQCv51sf7X6WhCKc
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwFH6CIaZdJn6TsYGRuHDIksaxkxxZoQxGS4WYtJsV_6JBbVJ1rUTP_ON7dpqpRTtxshQ7iuXvRf4--fl7AO-QZJSWpjK02h0zUmbDgus4ZLykqVEytcad6A5H_Pwy_XrFrrZKffmkfSWr03o6O62ric-tnM9U1OWJReNhP0Megsw2mmsb3YcHjGKQbQn13y3xpZSy9mASZVgR2Wo2W6EgTFwuFzYHsE9xv6PMuaxu7Uneuv8uvvlv2uTWPjR4BIcbAkk-tBN9DPdM_QQetiUl10_h7-fpGrF1PiOkrDX5_qfS3tubjCfN9XzSLNZt9hsZT8s16SodkB_O2IlUNRmV3omDXPhLgqRvpthpXPJLswiHvrCH0XeOGuAW6aP4GVwOPv3sn4ebQguhYkm-DAuDJK7AJUtyi43UhstcS2cbXCKlS1RhUUjFJjFxVuZcK1zbnko011yhvM7oc9irm9q8BCJxqFJIpKRC6ZhqmWcyzpWkuUampVgA77ulFvPWT0OgDnEICY-QcAgJj1AAZw6L23HOCds_aBa_xCYehCqltTrNuepZDC4mUTByg9PWPc2U0QG87ZAU-Oe445CyNs3qWiQUtRLSk14awIsW2dtPdZERQLaD-c5cdnswWL079yY4j_77zTewP_44EN--jC5ewYFbDn-FPj6GveViZU6QBC3lax_uN2CpCbo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Glycolysis+and+Oxidative+Phosphorylation+Play+Critical+Roles+in+Natural+Killer+Cell+Receptor-Mediated+Natural+Killer+Cell+Functions&rft.jtitle=Frontiers+in+immunology&rft.au=Zixi+Wang&rft.au=Zixi+Wang&rft.au=Di+Guan&rft.au=Di+Guan&rft.date=2020-02-20&rft.pub=Frontiers+Media+S.A&rft.eissn=1664-3224&rft.volume=11&rft_id=info:doi/10.3389%2Ffimmu.2020.00202&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_cabffd486c1f4ec5b4016ea05d1d5ced
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon